JPRN-UMIN000007720已完成未知
Metabolic Effect of Combined Telmisartan and Nifedipine CR Therapy in Patients with Essential Hypertension - Metabolic Effect of Combined Telmisartan and Nifedipine CR Therapy in Patients with Essential Hypertension
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 16
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 40years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients had diabetes mellitus, hypercholesterolemia, metabolic syndrome or cardiovascular disease and were not taking any anti-hypertensive medicines for at least 6 months.
研究者
相似试验
已完成
不适用
Metabolic effect of telmisartan and losartan in peritoneal dialysis patientsperitoneal dialysis patientsJPRN-C000000383Department of Internal Medicine,Osaka University School of Medicine Devision of Nephrology30
尚未招募
不适用
Effect of Combination tablets with telmisartan and amlodipine in hypertensive patients with metabolic syndrome not controlled by conventional therapy, randomized, open label, multicenter, parallel group studyJPRN-UMIN000005265Osaka University70
已完成
不适用
Effect of a standard dose of telmisartan combined with amlodipine and trichlormethiazide versus a high dose of telmisartan combined with trichlormethiazide on urinary excretion of albumin in hypertensive patients with type 2 diabetes mellitusType 2 diabetic patients with essential hypertension and albuminuriaJPRN-UMIN000005170agoya City University Graduate School of Medical Sciences40
尚未招募
不适用
Effects of high dose telmisartan or combination telmisartan/amlodipine on albuminuria in patients with hypertension and type 2 diabetesMicroalbuminuria in patients with diabetes and hypertensionJPRN-UMIN000006520Juntendo University, Department of Cardiovascular Medicine40
已完成
4 期
Therapeutic effects of telmisartan and irbesartan on hypertensive patients with overt diabetic nephropathyHypertension, type 2 diabetes, diabetic nephropathyJPRN-UMIN000001470Department of Cardiorenal Medicine, Yokohama City University School of Medicine60